Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.

@article{Okada2007AssociationBM,
  title={Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.},
  author={Tomonari Okada and Toshiyuki Nakao and Hiroshi Matsumoto and Tamami Shino and Yume Nagaoka and Ryo Tomaru and Toshikazu Wada},
  journal={Internal medicine},
  year={2007},
  volume={46 12},
  pages={807-14}
}
BACKGROUND AND OBJECTIVE The influence of glycemic control on cardiovascular (CV) complications or survival is not clear in diabetic patients with end-stage renal disease (ESRD). Although glycohemoglobin (HbA1c) is widely used as a marker of hyperglycemia in these patients, it may be unreliable because of shortened erythrocyte lifespan. Glycated albumin (GA) is an alternative marker. We investigated the relation between these markers and development of CV complications or survival in diabetic… CONTINUE READING